Grünenthal

Grünenthal is a global, family-owned pharmaceutical company headquartered in Aachen, Germany, specializing in pain management and related therapies. The company is a leader in the research, development, and commercialization of innovative treatments for chronic, neuropathic, and acute pain. Its portfolio includes well-known brands such as Palexia, Qutenza, and Versatis, alongside a robust pipeline focused on non-opioid alternatives. Grünenthal operates across the entire value chain, from early-stage R&D to specialized manufacturing and global distribution. The company aims to achieve a world free of pain by investing significantly in next-generation modalities like cell and gene therapy and highly specific small molecules.